We hypothesised that our analyses within the tumour microenvironment mimicked the progressive ‘endothelial-like switch’ of CD11c+ leukocytes observed in vitro, which appeared to first acquire CD34, increase CD31 expression, and progressively lose the expression of the haematopoietic marker CD45. This evidence concerns the gene PTPRC and neoplasm.